"","concept_name","domain","concept_id","total_patient_count"
"1","ALK gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative","measurement","21492148","62800"
"2","ETV6 (ETS variant transcription factor 6) gene variant measurement","measurement","35947772","28122"
"3","BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3020720","22927"
"4","BRCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3048642","20604"
"5","KRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","46235711","20300"
"6","BRAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","40761583","14335"
"7","Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection","measurement","3051552","12204"
"8","BCR-ABL gene RNA (ribonucleic acid) transcript measurement","measurement","44806067","10000"
"9","Genetic test","measurement","4237017","9682"
"10","MSH2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3052805","9182"
"11","MLH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3047555","9099"
"12","MSH6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3042350","8798"
"13","Janus kinase 2 V617F mutation analysis","measurement","44791465","7421"
"14","PROS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3051695","6586"
"15","NRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal","measurement","3022573","5872"
"16","Cells.chromosome region 11q22.3 deletion/Cells counted in Blood or Tissue by FISH","measurement","42527798","3621"
"17","BCR (BCR activator of RhoGEF and GTPase) gene variant measurement","measurement","35953732","3351"
"18","FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method","measurement","40757578","1646"
"19","BRIP1 (BRCA1 interacting protein C-terminal helicase 1) gene variant measurement","measurement","35960995","1346"
"20","MPL gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal","measurement","40765680","1174"
"21","CALR gene exon 9 full mutation analysis in Blood or Tissue by Sequencing","measurement","42528716","1142"
"22","Clinical cytogeneticist review of results","measurement","42868454","869"
"23","IgVH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3049502","833"
"24","Genetic analysis report","measurement","3040246","790"
"25","t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method","measurement","3013321","763"
"26","JAK2 gene exon 12 targeted mutation analysis in Bone marrow by Molecular genetics method","measurement","21494669","723"
"27","Hemochromatosis gene screening test","measurement","4293718","698"
"28","BRCA1+BRCA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3029984","620"
"29","Prothrombin gene (20210) screen","measurement","4216467","612"
"30","RPGR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method","measurement","46236933","585"
"31","Chronic lymphocytic leukemia gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3034608","578"
"32","JAK2 gene exon 13 targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","40758430","444"
"33","MPL gene p.Trp515Leu+Trp515Lys [Presence] in Blood or Tissue by Molecular genetics method","measurement","40759263","420"
"34","MPL gene p.Ser505Asn [Presence] in Blood or Tissue by Molecular genetics method","measurement","40759262","341"
"35","Molecular cytogenetics; DNA probe, each (eg, FISH)","measurement","2213269","305"
"36","Factor II (prothrombin) G20210A mutation detection test","measurement","44793427","249"
"37","BCL2 gene rearrangements [Presence] in Blood or Tissue by FISH","measurement","21492156","238"
"38","t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method","measurement","3049056","235"
"39","TSC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3049838","234"
"40","TSC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3049211","234"
"41","TSC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3030547","232"
"42","Cytogenetics and molecular cytogenetics, interpretation and report","measurement","2213278","227"
"43","AML/MDS gene CEP 8 trisomy [Presence] in Blood or Tissue by Molecular genetics method","measurement","3033703","221"
"44","MYB gene deletion [Presence] in Blood or Tissue by FISH","measurement","21492257","211"
"45","Gene studies","measurement","4194421","206"
"46","Chronic lymphocytic leukemia gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3040122","169"
"47","KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (eg, gastrointestinal stromal tumor [GIST], acute myeloid leukemia, melanoma), gene analysis, targeted sequence analysis (eg, exons 8, 11, 13, 17, 18)","measurement","42628605","159"
"48","t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel - Blood or Tissue by Molecular genetics method","measurement","3041524","159"
"49","DPYD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3046976","158"
"50","OCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3042708","158"
"51","BCR-ABL1 kinase domain mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","40758265","154"
"52","Molecular genetic test","measurement","4233623","154"
"53","MTHFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal","measurement","3014958","149"
"54","JAK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3048870","142"
"55","Shiga toxin stx gene [Identifier] in Specimen by NAA with probe detection","measurement","3033217","142"
"56","Targeted analysis for gene mutation","measurement","40484179","134"
"57","Genetic testing for alpha-thalassemia","measurement","2721213","132"
"58","TP53 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3009106","132"
"59","UGT1A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3045231","126"
"60","BCL2 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative","measurement","21492163","90"
"61","BRCA1 mutation carrier detection test","measurement","4228632","87"
"62","BRCA2 mutation carrier detection test","measurement","4226283","87"
"63","Myeloproliferative disorder comprehensive genetic test","measurement","45770189","84"
"64","CYP2D6 gene deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3035751","81"
"65","F2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal","measurement","3026139","80"
"66","Geneticist review of results","measurement","40771568","80"
"67","Chromosome region 13q14 deletion in Bone marrow by FISH","measurement","21494131","65"
"68","ERBB2 gene (HER2) duplication associated observations panel - Tissue by FISH","measurement","44816777","65"
"69","White blood cell cytogenetic investigation","measurement","4098069","65"
"70","t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method","measurement","3032765","64"
"71","t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method","measurement","44816910","49"
"72","t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Bone marrow by Molecular genetics method","measurement","42529040","49"
"73","t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method","measurement","40758277","46"
"74","EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3009224","40"
"75","Carbapenem resistance blaKPC gene [Presence] by Molecular method","measurement","3033281","38"
"76","Enterobacter sp gyrB+metB genes [Presence] by Probe in Positive blood culture","measurement","36303327","38"
"77","Methicillin resistance mecA gene [Presence] by Molecular method","measurement","3050167","38"
"78","t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method","measurement","3042391","34"
"79","t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Blood or Tissue by Molecular genetics method","measurement","3029271","29"
"80","Breakpoint cluster region c-abl oncogene 1 non-receptor tyrosine kinase targeted genetic test","measurement","45770186","28"
"81","t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method","measurement","42868452","28"
"82","ELA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3040460","26"
"83","CYP2D6 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","43533707","24"
"84","CYP2D6 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","43533706","24"
"85","HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method","measurement","3017312","19"
"86","HFE gene.p.Cys282Tyr [Presence] in Blood or Tissue by Molecular genetics method","measurement","3026898","17"
"87","Gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal","measurement","3036449","15"
"88","Borrelia garinii+afzelii oppA1 gene [Presence] in Specimen by NAA with non-probe detection","measurement","42528617","14"
"89","Borrelia mayonii oppA1 gene [Presence] in Specimen by NAA with non-probe detection","measurement","42528619","14"
"90","FISH probe target gene [Identifier] in Laboratory device","measurement","21492572","14"
"91","Factor II (prothrombin) G20210A mutation detection","measurement","40485488","14"
"92","ALK gene rearrangements [Presence] in Blood or Tissue by FISH","measurement","21492143","13"
"93","F2 gene c.20210G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal","measurement","3025008","13"
"94","F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3011836","12"
"95","Chromosome 17p13.1 deletion and 14q32 rearrangements in Bone marrow by FISH","measurement","21494133","10"
"96","Clostridioides difficile toxin B tcdB gene [Presence] in Stool by NAA with probe detection","measurement","44816714","10"
"97","HFE gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3044643","9"
"98","KIT gene D816V variant screen","measurement","44806459","9"
"99","9q34 chromosome region deletion [Presence] in Blood or Tissue by FISH","measurement","21492140","7"
"100","Detection of factor V Leiden mutation and prothrombin G20210A mutation","measurement","40485063","7"
"101","EGFR (epidermal growth factor receptor) (eg, non-small cell lung cancer) gene analysis, common variants (eg, exon 19 LREA deletion, L858R, T790M, G719A, G719S, L861Q)","measurement","43527945","7"
"102","UGT1A1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3039940","7"
"103","UGT1A1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3042387","7"
"104","CEBPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","40766729","6"
"105","Hepatitis B virus basal core promoter mutation [Identifier] in Serum by NAA with probe detection","measurement","40757341","6"
"106","t(5;12)(q33.1;p13)(PDGFRB,ETV6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method","measurement","3016002","6"
"107","KIT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","40758330","5"
"108","MYD88 gene p.Leu265Pro targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","21493201","5"
"109","CALR gene exon 9 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","46237016",">5"
"110","CYP2C9 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method","measurement","21491539",">5"
"111","EGFR gene exon 19 deletion [Presence] in Blood or Tissue by Molecular genetics method","measurement","40758885",">5"
"112","HIV protease gene mutations by Genotype method","measurement","3031311",">5"
"113","MLH1 gene methylation [Presence] in Blood or Tissue by Molecular genetics method","measurement","40761517",">5"
"114","PDGFRA gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method","measurement","40758222",">5"
"115","BBS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3032866",">5"
"116","BCR-ABL1 p210 Major Molecular Response (MMR) [Presence] in Blood or Tissue by Molecular genetics method --post treatment","measurement","44786698",">5"
"117","BRAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3039156",">5"
"118","CCND1 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method","measurement","3015389",">5"
"119","CDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3002489",">5"
"120","Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection","measurement","21493350",">5"
"121","MLL gene rearrangements in Blood or Tissue by Molecular genetics method","measurement","3037009",">5"
"122","PIK3CA gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal","measurement","36203351",">5"
"123","t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2+e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method","measurement","40766153",">5"
"124","20q chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal","measurement","3038647",">5"
"125","BBS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3048595",">5"
"126","BCL6 gene rearrangements [Presence] in Blood or Tissue by FISH","measurement","21492141",">5"
"127","BRCA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal","measurement","3002832",">5"
"128","CYP2C19 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method","measurement","21491537",">5"
"129","CYP2C9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","21493567",">5"
"130","Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with probe detection","measurement","21493566",">5"
"131","Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes [Presence] in Stool by NAA with non-probe detection","measurement","21492843",">5"
"132","Escherichia coli enteropathogenic eae gene [Presence] in Stool by NAA with non-probe detection","measurement","21492842",">5"
"133","FISH probe gene name [Identifier] in Laboratory device","measurement","40765111",">5"
"134","Genetic testing for hemoglobin e beta-thalassemia","measurement","2721214",">5"
"135","IGH@ (Immunoglobulin heavy chain locus) (eg, leukemias and lymphomas, B-cell), gene rearrangement analysis to detect abnormal clonal population(s); amplified methodology (eg, polymerase chain reaction)","measurement","42742314",">5"
"136","MGMT gene methylation score in Tissue by Molecular genetics method","measurement","40766799",">5"
"137","PDGFRA gene exon 18 targeted mutation analysis in Blood or Tissue by Sequencing","measurement","42870299",">5"
"138","VKORC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3030676",">5"
"139","t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method","measurement","3053306",">5"
"140","t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method","measurement","3020893",">5"
"141","t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [#/volume] in Blood or Tissue by Molecular genetics method","measurement","3029230",">5"
"142","ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib tyrosine kinase inhibitor resistance), gene analysis, variants in the kinase domain","measurement","42627942",">5"
"143","Alpha thalassemia gene panel - Blood by Molecular genetics method","measurement","40758363",">5"
"144","BRCA2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal","measurement","3049254",">5"
"145","CALR (calreticulin) targeted genetic test","measurement","45770652",">5"
"146","Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH","measurement","21493619",">5"
"147","DYS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3028927",">5"
"148","FGFR1 gene rearrangements [Presence] in Blood or Tissue by FISH","measurement","21491670",">5"
"149","FLT3 gene internal tandem duplication [Presence] in Bone marrow by Molecular genetics method","measurement","42527977",">5"
"150","HBB gene c.20A>T [Presence] in Blood by Molecular genetics method","measurement","40758371",">5"
"151","HBB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal","measurement","3006458",">5"
"152","MTHFR gene c.1298A>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal","measurement","3024185",">5"
"153","MTHFR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3047756",">5"
"154","NPM1 gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal","measurement","44816925",">5"
"155","SERPINA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal","measurement","3003648",">5"
"156","Screen for Janus kinase 2 gene mutation","measurement","44806179",">5"
"157","TCRB gene rearrangements [Presence] in Bone marrow by Molecular genetics method","measurement","40763637",">5"
"158","TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method","measurement","40763634",">5"
"159","TPMT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method","measurement","3037060",">5"
"160","t(11;14)(q13;q32)(CCND1,IGH) cells/Cells.total in Blood or Tissue by Molecular genetics method","measurement","3010746",">5"
"161","t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Bone marrow by Molecular genetics method","measurement","43054999",">5"
"162","t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method","measurement","3034974",">5"
